Diet Drug Yanked Over Cancer Risk

12:18 EST 13 Feb 2020 | MedPageToday

]]>(MedPage Today) -- WASHINGTON -- The FDA called for a voluntarily recall of the weight management drug lorcaserin (Belviq, Belviq XR) after data from a postmarketing trial suggested increased cancer risk with the agent. Manufacturer Eisai will...

Original Article: Diet Drug Yanked Over Cancer Risk


More From BioPortfolio on "Diet Drug Yanked Over Cancer Risk"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Diabetes Diabetes Endocrine Disorders Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several g...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...